RXO Inc. price target raised to $26 from $19 at Morgan Stanley

Morgan Stanley raised the firm’s price target on RXO Inc. to $26 from $19 and keeps an Equal Weight rating on the shares. RXO reported a modest beat for Q2, and while the upcycle and upcoming Coyote acquisitions are “exciting” catalysts ahead, the market has already priced in a lot of the potential upside, leaving risk-reward looking fairly balanced, the analyst tells investors in a research note.